跳至主要内容
临床试验/CTRI/2020/02/023214
CTRI/2020/02/023214进行中(未招募)未知

Effects of clozapine on immunoglobulins and interleukin levels and its clinical correlation in patients with schizophrenia

Government medical college and hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diagnosis of schizophrenia according to ICD-11
  • Drug naïve/ not on any antipsychotic drug for more than 2 weeks.

排除标准

  • Patient on immunosuppressants
  • Patients with overt infection in the past 2 weeks, hematological disorders, chronic liver or kidney disease, autoimmune disorders and chronic inflammatory disease
  • Patient on antibiotics (chloramphenicol, tetracycline, rifampicin, polymyxin b, nitrofurantoin)
  • Patients with known immunodeficiency disorder
  • Patients with epilepsy
  • Patients unable to tolerate clozapine
  • Patients with agranulocytosis or granulocytopenia
  • Patients with paralytic ileus, CNS depression, myeloproliferative disorder
  • Patients with substance use disorder except tobacco and caffeine
  • Pregnant and lactating women
  • Patient who have received depot antipsychotics in the past 3 months

研究者

发起方
Government medical college and hospital

相似试验